These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 11566916)
41. Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy. Olsen MH; Hjerkinn E; Wachtell K; Høieggen A; Bella JN; Nesbitt SD; Fossum E; Kjeldsen SE; Julius S; Ibsen H J Hum Hypertens; 2003 May; 17(5):305-11. PubMed ID: 12756402 [TBL] [Abstract][Full Text] [Related]
45. Left ventricular midwall mechanics in subjects with aortic stenosis and normal systolic chamber function. Ballo P; Mondillo S; Motto A; Faraguti SA J Heart Valve Dis; 2006 Sep; 15(5):639-50. PubMed ID: 17044369 [TBL] [Abstract][Full Text] [Related]
46. Effects of coronary blood flow on left ventricular function in essential hypertensive patients. Sasaki O; Hamada M; Hiwada K Hypertens Res; 2000 May; 23(3):239-45. PubMed ID: 10821133 [TBL] [Abstract][Full Text] [Related]
47. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Devereux RB; de Simone G; Pickering TG; Schwartz JE; Roman MJ Hypertension; 1998 Apr; 31(4):929-36. PubMed ID: 9535417 [TBL] [Abstract][Full Text] [Related]
48. Early regression of left ventricular diastolic abnormalities in hypertensive patients treated with nifedipine. Sheiban I; Covi G; Zenorini C; Arcaro G; Arosio E; Tonni S; Montresor G; Lechi A Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():957-61. PubMed ID: 2076407 [TBL] [Abstract][Full Text] [Related]
49. Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint. Wachtell K; Rokkedal J; Bella JN; Aalto T; Dahlöf B; Smith G; Roman MJ; Ibsen H; Aurigemma GP; Devereux RB Am J Cardiol; 2001 Jan; 87(1):54-60. PubMed ID: 11137834 [TBL] [Abstract][Full Text] [Related]
50. Left ventricular mass and systolic dysfunction in essential hypertension. Schillaci G; Vaudo G; Pasqualini L; Reboldi G; Porcellati C; Verdecchia P J Hum Hypertens; 2002 Feb; 16(2):117-22. PubMed ID: 11850769 [TBL] [Abstract][Full Text] [Related]
51. Left ventricular chamber and wall mechanics in the presence of concentric geometry. de Simone G; Devereux RB; Celentano A; Roman MJ J Hypertens; 1999 Jul; 17(7):1001-6. PubMed ID: 10419074 [TBL] [Abstract][Full Text] [Related]
52. Exploratory assessment of left ventricular strain-volume loops in severe aortic valve diseases. Hulshof HG; van Dijk AP; George KP; Hopman MTE; Thijssen DHJ; Oxborough DL J Physiol; 2017 Jun; 595(12):3961-3971. PubMed ID: 28117492 [TBL] [Abstract][Full Text] [Related]
53. Systolic-diastolic functional coupling in healthy children and in those with dilated cardiomyopathy. Friedberg MK; Margossian R; Lu M; Mercer-Rosa L; Henderson HT; Nutting A; Friedman K; Molina KM; Altmann K; Canter C; Sleeper LA; Colan SD; J Appl Physiol (1985); 2016 Jun; 120(11):1301-18. PubMed ID: 26940654 [TBL] [Abstract][Full Text] [Related]
54. Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance. Starling MR Am Heart J; 1994 Jul; 128(1):124-33. PubMed ID: 8017265 [TBL] [Abstract][Full Text] [Related]
55. Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease. Cioffi G; Viapiana O; Ognibeni F; Dalbeni A; Gatti D; Mazzone C; Faganello G; Di Lenarda A; Adami S; Rossini M J Am Soc Echocardiogr; 2016 Jul; 29(7):689-98. PubMed ID: 26922258 [TBL] [Abstract][Full Text] [Related]
56. Impact of disease activity on left ventricular performance in patients with acromegaly. Bruch C; Herrmann B; Schmermund A; Bartel T; Mann K; Erbel R Am Heart J; 2002 Sep; 144(3):538-43. PubMed ID: 12228793 [TBL] [Abstract][Full Text] [Related]
57. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Wachtell K; Bella JN; Rokkedal J; Palmieri V; Papademetriou V; Dahlöf B; Aalto T; Gerdts E; Devereux RB Circulation; 2002 Mar; 105(9):1071-6. PubMed ID: 11877357 [TBL] [Abstract][Full Text] [Related]
58. Effects of aging on left ventricular relaxation in humans. Analysis of left ventricular isovolumic pressure decay. Yamakado T; Takagi E; Okubo S; Imanaka-Yoshida K; Tarumi T; Nakamura M; Nakano T Circulation; 1997 Feb; 95(4):917-23. PubMed ID: 9054751 [TBL] [Abstract][Full Text] [Related]
59. The mechanism of reduced longitudinal left ventricular systolic function in hypertensive patients with normal ejection fraction. Szelényi Z; Fazakas Á; Szénási G; Tegze N; Fekete B; Molvarec A; Hadusfalvy-Sudár S; Jánosi O; Kiss M; Karádi I; Vereckei A J Hypertens; 2015 Sep; 33(9):1962-9; discussion 1969. PubMed ID: 26154942 [TBL] [Abstract][Full Text] [Related]
60. Peak exercise oxygen uptake and left ventricular systolic and diastolic function and arterial mechanics in healthy young men. Palmieri V; Palmieri EA; Arezzi E; Innelli P; Sabatella M; Ferrara LA; Fazio S; Celentano A Eur J Appl Physiol; 2004 May; 91(5-6):664-8. PubMed ID: 14652763 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]